Results of Liver Resection
Since the goal of surgical treatment is to prolong survival, patient survival data are the best measure of success. Disease-free survival data are inherently inaccurate due to the difficulties with detection of disease and variability of follow-up. Thus, this discussion is limited to patient survival data.
Two large multicenter studies have been reported. Nordlinger et al 6 reported data from a French Association of Surgery study, which analyzed 1,118 patients who underwent potentially curative liver resection at 85 centers from 1959 to 1991. Actuarial survival was 84% at one year, 40% at three years, and 25% at five years. Hughes et al 7 compiled data from 859 patients treated at 24 centers from 1948 to 1985 in which actuarial five-year patient survival was 33% (excluding perioperative deaths). Five institutions have reported experiences with 100 or more patients with 25% to 37% actuarial five-year survival and 28-to 34-month median survival. 5, [8] [9] [10] [11] In most centers, operative mortality is less than 5%. Long-term follow-up from the Mayo Clinic series of 280 patients treated from 1960 to 1987 showed a 20% probability of survival 10 years after potentially curative resection.
12 Surprisingly, results with repeat liver resection mirror those for initial liver resection. Repeat resections, when possible, seem to "reset the clock"; a 3.4-year median survival and a 30% five-year survival was reported in a series of 21 patients treated at the Mayo Clinic. 13 
Determinants of Prognosis
The most important determinant of prognosis is tumor amenable to complete removal by a potentially curative resection. There is no difference in survival between patients treated with incomplete removal of tumor (debulking) and patients not treated at all. 3 Many patient and primary tumor features, metastatic disease features, and intervention factors have been examined in order to determine which patients should and should not undergo liver resection. 14 Perihepatic lymph node involvement portends a poor prognosis and is considered by many to be a contraindication for resection. Locally recurrent disease or extrahepatic metastases are also associated with poor survival and are relative contraindications for resection. Other factors less significantly associated with adverse prognosis are the presence of symptoms, large tumor size and multiplicity, satellite configuration of metastases, extensive liver involvement, a high preresection serum carcinoembryonic antigen (CEA) level, presence of nondiploid tumors, a requirement for perioperative blood transfusion, and a margin of resection less than 1 cm. Although these and other putative prognostic determinants have been identified, the significance of each varies greatly among studies. Furthermore, the actual differences in survival associated with these determinants are often so small that the presence of a factor has little influence on clinical decisions.
Preferred Approach to Patient Care
The promising results with liver resection warrant close follow-up of all patients with a history of primary colonic and rectal carcinoma, and all patients with metastatic disease should be evaluated for liver resection. Evaluation should include a complete physical examination, blood tests including a CEA level, colonoscopy or proctoscopy with barium enema to rule out locally recurrent or metachronous disease, a chest computed tomography (CT) scan to rule out pulmonary metastases, and an abdominal/pelvic CT scan to rule out extrahepatic and locally recurrent disease. Operation should be considered if there is no evidence for unresectability and if expectant morbidity and mortality are low. The operation should include a thorough abdominal exploration to rule out locally recurrent and extrahepatic metastases. Several regional hepatic lymph nodes should be excised and examined by frozen section before proceeding with liver resection. Intraoperative ultrasound is helpful in planning the resection and detecting unrecognized metastatic lesions in 10% to 15% of patients. An anatomically appropriate resection should be performed with an attempt to obtain at least a 1-cm margin of parenchyma surrounding each lesion. Inflow occlusion and total vascular isolation are helpful aids for the resection of large tumors, multiple tumors, and tumors close to major vascular structures such as the vena cava. For metastases presenting at the time of diagnosis of the primary tumor, liver resection may be performed during the primary tumor procedure if the procedure is uncomplicated, exposure is satisfactory, and both procedures can be done safely.
